Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02356198 · ClinicalTrials.gov registry record · NA
Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery
A NA study, sponsored by Mayo Clinic.
- Completed
- Registry status
- NA
- Development phase
- 209
- Enrollment target
NCT02356198: Completed NA study, sponsored by Mayo Clinic.
NCT02356198 is a NA study that has completed, run by Mayo Clinic. The registered enrollment target is 209 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02356198, a NA study, has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 209 participants
- Enrollment target
Study Summary
This study is prospective, randomized trial in which EXPAREL TAP block is compared to standard IT opioid administration, in relieving postoperative pain, decreasing length of stay, and use of narcotic medication.
Interventions
- DRUG EXPAREL
- DRUG Intrathecal hydromorphone
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 209 participants |
| Start Date | 2015-03 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02356198
The ClinicalTrials.gov registry entry for NCT02356198 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 209 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which EXPAREL is the first listed.
NCT02356198 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02356198 about?
NCT02356198 is a clinical study titled "Exparel Transversus Abdominis Plane Block vs Intrathecal Analgesia In Colorectal Surgery". This study is prospective, randomized trial in which EXPAREL TAP block is compared to standard IT opioid administration, in relieving postoperative pain, decreasing length of stay, and use of narcotic medication.
What is the current status of trial NCT02356198?
This trial is currently completed. It is a NA study. The enrollment target is 209 participants. The study started on 2015-03. Estimated completion is 2017-10.
What interventions are being tested in trial NCT02356198?
The interventions under investigation include: EXPAREL (DRUG), Intrathecal hydromorphone (DRUG).
Who is sponsoring clinical trial NCT02356198?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.